Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ruboxistaurin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Ruboxistaurin?

Ruboxistaurin is an investigational drug.

There have been 13 clinical trials for Ruboxistaurin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2002.

The most common disease conditions in clinical trials are Diabetes Mellitus, Diabetes Mellitus, Type 1, and Diabetic Neuropathies. The leading clinical trial sponsors are Chromaderm, Inc., Eli Lilly and Company, and Children's Hospital Medical Center, Cincinnati.

Recent Clinical Trials for Ruboxistaurin
Ruboxistaurin in New York Heart Failure Classification III-IV PatientsThe Christ HospitalPhase 1/Phase 2
Ruboxistaurin in New York Heart Failure Classification III-IV PatientsChildren's Hospital Medical Center, CincinnatiPhase 1/Phase 2
Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes MellitusHeart and Stroke Foundation of CanadaPhase 3

See all Ruboxistaurin clinical trials

Clinical Trial Summary for Ruboxistaurin

Top disease conditions for Ruboxistaurin
Top clinical trial sponsors for Ruboxistaurin

See all Ruboxistaurin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.